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compared with dementia prevalence estimates based on meta-analyses
Abstract
Background
Background: National data on dementia prevalence are not always available, yet it may be possible to
obtain estimates from large surveys that include dementia screening instruments. In Australia, many of
the dementia prevalence estimates are based on European data collected between 15 and 50 years ago.
We derived populationbased estimates of probable dementia and possible cognitive impairment in
Australian studies using the Mini-Mental State Examination (MMSE), and compared these to estimates of
dementia prevalence from meta-analyses of European studies.
Methods
Methods: Data sources included a pooled dataset of Australian longitudinal studies (DYNOPTA), and two
Australian Bureau of Statistics National Surveys of Mental Health and Wellbeing. National rates of
probable dementia (MMSE < 24) and possible cognitive impairment (24-26) were estimated using
combined sample weights.
Results
Results: Estimates of probable dementia were higher in surveys than in meta-analyses for ages 65-84, but
were similar at ages 85 and older. Surveys used weights to account for sample bias, but no adjustments
were made in metaanalyses. Results from DYNOPTA and meta-analyses had a very similar pattern of
increase with age. Contrary to trends from some meta-analyses, rates of probable dementia were not
higher among women in the Australian surveys. Lower education was associated with higher prevalence
of probable dementia. Data from investigator-led longitudinal studies designed to assess cognitive
decline appeared more reliable than government health surveys.
Conclusions
Conclusions: This study shows that estimates of probable dementia based on MMSE in studies where
cognitive decline and dementia are a focus, are a useful adjunct to clinical studies of dementia
prevalence. Such information and may be used to inform projections of dementia prevalence and the
concomitant burden of disease.
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Estimates of probable dementia prevalence from
population-based surveys compared with
dementia prevalence estimates based on
meta-analyses
Research article

Kaarin J Anstey*1, Richard A Burns1, Carole L Birrell2, David Steel2, Kim M Kiely1 and Mary A Luszcz3

Abstract
Background: National data on dementia prevalence are not always available, yet it may be possible to obtain
estimates from large surveys that include dementia screening instruments. In Australia, many of the dementia
prevalence estimates are based on European data collected between 15 and 50 years ago. We derived populationbased estimates of probable dementia and possible cognitive impairment in Australian studies using the Mini-Mental
State Examination (MMSE), and compared these to estimates of dementia prevalence from meta-analyses of European
studies.
Methods: Data sources included a pooled dataset of Australian longitudinal studies (DYNOPTA), and two Australian
Bureau of Statistics National Surveys of Mental Health and Wellbeing. National rates of probable dementia (MMSE < 24)
and possible cognitive impairment (24-26) were estimated using combined sample weights.
Results: Estimates of probable dementia were higher in surveys than in meta-analyses for ages 65-84, but were similar
at ages 85 and older. Surveys used weights to account for sample bias, but no adjustments were made in metaanalyses. Results from DYNOPTA and meta-analyses had a very similar pattern of increase with age. Contrary to trends
from some meta-analyses, rates of probable dementia were not higher among women in the Australian surveys. Lower
education was associated with higher prevalence of probable dementia. Data from investigator-led longitudinal
studies designed to assess cognitive decline appeared more reliable than government health surveys.
Conclusions: This study shows that estimates of probable dementia based on MMSE in studies where cognitive
decline and dementia are a focus, are a useful adjunct to clinical studies of dementia prevalence. Such information and
may be used to inform projections of dementia prevalence and the concomitant burden of disease.
Background
In 2005 it was estimated that the number of people with
dementia in Australia reached 200,000 [1]. Recent projections indicate that if there is no risk reduction at the population level, the number of people with dementia in
Australia will exceed 730,000 by 2050 [2]. In Australia,
dementia will cause the largest burden of disease for
women and 5th largest for men by 2016 [3]. These Australian figures were derived using a similar methodology
to European studies that project future population char* Correspondence: kaarin.anstey@anu.edu.au
1
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acteristics by age and sex [4] and took into account prevalence estimates from four meta-analyses of mostly
European studies [5-8]. Consequently, estimates of
dementia prevalence in Australia are typically based on
non-Australian studies and it is necessary to compare
those estimates derived from European and North America studies with large scale Australian studies.
Many of the dementia prevalence studies included in
the source meta-analyses [5-8] were published 15 to 50
years ago, with the actual data often having been collected years prior to publication. For example, one metaanalysis is based on articles published between 1945 and
1985 [8], another analysed articles published between
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1981 and 1991 (mean publication year 1988) [6] and a
third covered publications between 1987 and 1994. Not
all studies contributing to these meta-analyses were population-based studies as some of the samples were drawn
from medical practitioner lists [6]. Diagnostic criteria for
dementia have changed since these studies were conducted and the methodology of meta-analyses has also
become more rigorous with the publication of guidelines
[9,10] and the development of the Cochrane Collaboration.
Whilst acknowledging that meta-analyses are the preferred method for aggregating data on dementia prevalence [1,2], their limitations prompt closer scrutiny of
complementary sources of data. This is particularly
important because prevalence estimates are used for service planning, and estimates of health care costs and burden of disease. When projected up to the population,
small differences in prevalence rates have large implications for estimating health care costs. For example, 1%
increase in dementia for the year 2003 in Australia would
have cost approximately AUD $217 million [11].
The aim of the present study was to compare prevalence of probable dementia and cognitive impairment
using MMSE cut-offs [12] with dementia prevalence estimates[1,2] generated by application of techniques used in
meta-analyses of European studies. The MMSE, was chosen because it is the most widely used screening instrument for dementia. Furthermore, the MMSE is used
almost universally in clinics [13], is recommended as a
dementia screen by the U.S. Preventive Services Task
Force [14], has been translated into many languages, and
has psychometric properties that have been well documented in many contexts [15].
The current methodology was adopted not only
because existing projections have relied on estimates that
are at least 15 years old and largely based on meta-analyses of European data, but also because there is no
national study of dementia prevalence in Australia that
uses clinical diagnoses. This is in part due to the cost of
acquiring dementia diagnoses and the logistical difficulty
of conducting a national prevalence study over such a
large land mass, in comparison to geographically smaller
countries. Data come from two sources: Australian
Bureau of Statistics (ABS) Surveys and a pooled, harmonized, dataset from DYNOPTA [16]. The latter includes
three independent regional studies that have reported
dementia prevalence in Australia, but none of these studies individually is large enough on which to base national
estimates. These include the Sydney Older Persons' study
(SOPS) that used a clinical diagnosis [17,18], the Canberra Longitudinal Study (CLS) that used an algorithm
based on data collected by a trained interviewer [19], and
the PATH Through Life Study (PATH) [20] that includes
a clinical assessment but which to date has identified very

Page 2 of 12

few cases because the sample is too young. These three
studies all included the Mini-Mental State Examination
as did a fourth study contributing to DYNOPTA, the
Australian Longitudinal Study of Ageing (ALSA). While
the latter did not include a clinical assessment of dementia, it included a cognitive assessment, and cognitive
decline and impairment has been a focus of the investigators. The ABS surveys recently have incorporated the
MMSE, providing an additional source of data to evaluate
for the estimation of probable dementia prevalence.

Methods
Data sources

Two types of population-based MMSE data were analyzed to obtain estimates of the prevalence of probable
dementia and possible cognitive impairment among older
Australians [1,2]. The first type of data was drawn from
the Dynamic Analyses to Optimise Ageing (DYNOPTA)
dataset [16]. DYNOPTA comprises a pooled dataset
comprising information from nine Australian Longitudinal Studies of Ageing (N = 50652). Data were harmonised
from the contributing studies to create an entirely new
and unique dataset. The research program of DYNOPTA
focuses on four outcomes that contribute greatly to the
burden of disease and disability, namely dementia and
cognition, mental health, sensory impairment, and mobility/activity limitations. The present study forms part of
the program on dementia and cognition. Four studies
contributing to DYNOPTA had cognitive decline or
dementia as a key focus of investigators and included
SOPS, CLS, PATH and ALSA. These studies contributed
data on the MMSE among participants aged 65 and older
(n = 3908). SOPS used a stratified sampling design, combining a random sample from a Department of Veteran's
Affairs listing of veterans and war widows over the age of
75 and a community area random sample of census collection districts from 8 Local Government Areas in the
inner west of Sydney during the years 1991-1994. Clinical
interview and cognitive assessments were made by a
trained geriatrician providing clinical diagnoses of
dementia against which to validate the MMSE cutoffs
used in the current study. The CLS, PATH and ALSA
were all sampled from the electoral roll, and voting is
compulsory in Australia. ALSA randomly sampled both
community dwelling and institutional residents aged over
70 and also sampled by convenience co-residents and
partners aged over 65 years from the Adelaide metropolitan area during the years 1992-1993. CLS randomly sampled both community dwelling and institutional residents
aged over 70 from the Australian Capital Territory and
Queanbeyan during 1991. CLS used a diagnostic algorithm to generate DSM-III diagnoses of dementia based
on a cognitive assessment. These diagnoses were used to
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evaluate the clinical cutoffs for the MMSE used in
DYNOPTA in addition to the data provided by SOPS.
The second type of population-based data was the ABS
National Surveys of Mental Health which were conducted in 1997 and 2007. The 1997 National Survey of
Mental Health and Wellbeing of Adults (97 NSMH) was a
stratified, multistage area sample of private dwellings
framed by 1991 census collection districts. The sample
included 10641 participants aged over 18, of whom 1788
were aged 65 or older and completed the MMSE [21]. A
second survey conducted in 2007 (07 NSMH), was also
framed by a stratified, multistage area sample of private
dwellings that excluded remote areas. It included 8800
participants aged between 16 and 85 [22], of whom 1905
were aged 65 and over and completed the MMSE [23].
Table 1 shows the sample characteristics of the datasets.
Data preparation and variable description

MMSE item and total scores were imputed for
DYNOPTA, 97 NSMH and 07 NSMH. For the
DYNOPTA dataset, MMSE items from contributing
studies were harmonized to provide equivalent scoring.
Multiple imputation, using the MICE module in STATA
v.10, computed total MMSE scores from available item

Page 3 of 12

level data, age, sex, and education with a cohort variable
that reflected the contributing study from which a participant was included. Five imputed datasets were computed
from which total imputed scores were averaged to create
an MMSE total score for the DYNOPTA data file. Due to
study differences in coding of non-response, a conservative approach was taken whereby all missing data was
imputed, regardless of nature of non-response. Based on
validation work of the imputation undertaken by the
authors (not reported here), cases with more than 50%
missing data (n = 105) on the MMSE were excluded. A
further 437 (10.97%) had missing item level data on the
MMSE which was imputed. For the NHMS datafiles the
rates of missing data at item level were much lower for
both the 97 (n = 61; 3.4%) and '07 (n = 88; 4.6%) datasets.
The NSMH was imputed using the same method as that
described for DYNOPTA. Categories based on MMSE
scores were also created and divided according to probable dementia (MMSE<24), possible cognitive impairment
(MMSE = 24 to 26) and no cognitive impairment (MMSE
>26).
The cutoff of 23/24 for probable dementia is widely recommended and has been validated in studies of the sensitivity and specificity of the MMSE [24-27]. The range

Table 1: Sample characteristics of DYNOPTA, the 97 NSMH and 07 NSMH
DYNOPTA

97NSMH

07NSMH

3908

1788

1905

Male

1954 (50.0%)

728 (40.7%)

904 (47.5%)

Female

1954 (50.0%)

1060 (59.3%)

1001 (52.5%)

65-69

441 (11.3%)

576 (32.2%)

636 (33.4%)

70-74

931 (23.8%)

499 (27.9%)

468 (24.6%)

75+

2536 (64.9%)

713 (39.9%)

801 (42.0%)

75-79

1099 (28.1%)

-

444 (23.3%)

80-84

797 (20.4%)

-

357 (18.7%)

85-89

458 (11.7%)

-

-

90-94

140 (3.6%)

-

-

95+

42 (1.1%)

-

-

14 (0.4%)

-

-

some or all of primary school or secondary school

2172 (55.6%)

-

-

non-tertiary study (i.e. apprenticeship/trade, certificate, undergraduate diploma

1137 (29.1%)

-

-

tertiary study (bachelor degree, post-graduate diploma, higher degree)

321 (8.2%)

-

-

Missing - No Response/Educated Overseas

264 (6.8%)

-

-

Yes

-

502 (28.1%)

420 (22.0%)

No

-

1286 (71.9%)

1485 (78.0%)

Total N
Gender (n, %)

Age (n, %)

Education (n, %)
no formal education

-

Finished secondary school
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from 24 to 26 has less empirical support for defining possible cognitive impairment than the cut-off of < 24 does
for defining probable dementia. It was based on the only
Australian epidemiological data on MMSE ranges in mild
cognitive disorders from the PATH Through Life Study
[20]. This study provided clinical diagnoses of mild cognitive disorders that were used to validate the MMSE
score.
Demographic variables

Demographic variables included in the analyses were agegroup, sex and education. The 97NMHS only recorded a
categorical age value for participants aged over 75, so the
data for this age-group is aggregated. The education variable for DYNOPTA included four levels (No formal education, some or all primary or secondary school, postsecondary, and tertiary study). The education variable for
the 97 NSMH was a binary variable indicating whether
the respondent had finished secondary school. A compatible binary variable was created from the 07 NSMH item
asking the highest year of school completed.
Study weights and Statistical analyses

To produce estimates from a sample survey weights are
usually calculated to account for differences in probabilities of selection and to ensure consistency with population benchmarks. Weights are provided for NSMH
participants at both time waves. For the DYNOPTA population, weights were already available for ALSA but CLS,
PATH and SOPS did not have study weights available. For
each of these studies weights were developed to adjust
the sample in each study to the specific population from
which it was drawn and account for the probability of
selection of each individual. These weights were then
benchmarked to the Estimated Resident Population
(ERP) for the relevant year, sex, age-group and geographical area. For ALSA, the 1992 ERP for Adelaide was used;
for CLS, the 1991 ERP for ACT was used; for PATH, the
2001 ERP for ACT was used; and for SOPS, the 1991 ERP
for the two relevant groupings of Local Government
Areas (LGA) in Sydney were used. To enable analysis
using the pooled data set, which consists of the data from
the four studies, final combined weights were calculated.
The final weights combined the study specific weights
according to their contributing sample sizes to the pooled
data set. These combined weights were then benchmarked by age-group and sex to the 1991 Australian ERP
and then used in the estimation. Although the PATH
study was conducted in 2001, it only contributed to the
65-69 year age-group. The estimated standard errors for
the prevalence estimates take into account the use of
weights and the complex survey design for each study
and also the number of multiple imputations used in the
analysis. Using the combined weights in the estimation
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procedure adjusts for the unequal probabilities of selection in the studies and allows for the contribution of the
individual study to the pooled data set. For the mean estimates reported in Table 2, the weighted estimates were
very similar to the unweighted estimates. For the estimation of the proportions in Table 3, the weights had more
impact on the proportions when the sample size within
the age-group by sex cell is small, such as in the over 90
age-groups for males.
Comparisons between datasets were conducted using
tests of proportions. Logistic regression was used to evaluate gender by age interactions in prevalence of probable
dementia. The sensitivity and specificity of the newly created MMSE probable dementia diagnosis in DYNOPTA
was validated by comparing it with data available on clinical diagnoses for the SOPS [17] and CLS [19] studies that
contributed to the DYNOPTA pooled dataset. Sample
weights were used in analyses of DYNOPTA, the 97
NSMH and the 07 NSMH.

Results
Description of samples

The sample characteristics of the DYNOPTA, 97 NSMH
and 07 NSMH are shown in Table 1. DYNOPTA has
equal proportions of males and females, while the 97
NSMH (χ2 = 61.447; df = 1; p < .001) and 07 NSMH (χ2 =
4,738; df = 1; p < .05) have higher proportion of females.
The 97 NSMH lacks information on age by year for adults
aged over 75 years which limits comparison with other
data.
The information on education for each study was different and hence could not be harmonized. In
DYNOPTA, whilst nearly half the sample completed
some or all schooling, 37.3% reported post-secondary
training, including 8.2% who undertook some tertiary
studies. In the 97 NSMH and 07 NSMH only 28% and
21% reported finishing their secondary schooling respectively.
Sensitivity and specificity of the MMSE in DYNOPTA

The CLS clinical diagnosis was based on two algorithms
based on the DSM-IIIR [28]or ICD-10 criteria [29]. For
the CLS, the MMSE specificity for 23/24 cutoff for diagnosing probable dementia, was 96% (CI 92%-99%) and
sensitivity was 75% (CI = 73% to 75%). The SOPS clinical
diagnoses were conducted by clinicians using DSM-IIIR
[28], DSM-IV [30], and NINCDS [31] criteria. Using the
clinical diagnoses of dementia from the SOPS study, the
23/24 threshold on the MMSE had a 91% (CI = 88%-94%)
sensitivity and 60% (CI = 58%-62%) specificity. Using data
from both studies the 23/24 MMSE cutoff for probable
dementia had a 93.06% (CI: 90.66-94.89%) sensitivity and
70.20% (CI: 69.09% to 71.28%) specificity. Clinical data
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Table 2: Mean (standard error) of MMSE scores for the DYNOPTA baseline population and NSMH (aged 65+) as a whole, by gender and by age cohort
DYNOPTA
Age Groups
65-69

70-74

75+

75-79

Anstey et al. BMC Neurology 2010, 10:62
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80-84

85-89

90-94

Total

97NSMH

07NSMH

N

Mean

Std. Err

95% Conf. Interval

N

Mean

Std. Err

95% Conf. Interval

N

Mean

Std. Err

95% Conf. Interval

441

28.73

0.13

28.48 - 28.98

576

27.71***

0.14

27.09 - 28.34

636

28.70

0.08

28.49 - 28.90

Males

162

28.69

0.17

28.35 - 29.04

283

27.28**

0.18

26.37 - 28.20

333

28.62

0.10

28.28 - 28.96

Females

279

28.77

0.20

28.38 - 29.16

293

28.16

0.17

27.68 - 28.63

303

28.76

0.11

28.50 - 29.03

Total

931

27.58

0.12

27.34 - 27.82

499

27.20

0.16

26.49 - 27.92

468

28.39*

0.10

28.14 - 28.64

Males

483

27.43

0.12

27.19 - 27.67

200

26.80*

0.28

25.93 - 27.66

241

28.30

0.14

28.01 - 28.60

Females

448

27.71

0.18

27.35 - 28.07

299

27.49

0.19

26.75 - 28.22

227

28.47

0.14

28.14 - 28.80

Total

2536

26.27

0.09

26.08 - 26.45

713

26.40

0.17

24.94 - 27.87

801

27.90**

0.09

27.69 - 28.11

Males

1309

26.35

0.11

26.14 - 26.56

245

26.36

0.33

24.41 - 28.30

330

27.75

0.14

27.36 - 28.15

Females

1227

26.22

0.13

25.97 - 26.47

468

26.43

0.19

25.14 - 27.71

471

28.02

0.11

27.78 - 28.26

Total

1099

26.98

0.11

26.76 - 27.21

444

28.07**

0.12

27.97 - 28.16

Males

589

26.95

0.14

26.68 - 27.22

198

27.82*

0.19

27.67 - 27.97

Females

510

27.01

0.16

26.69 - 27.33

246

28.26

0.15

28.15 - 28.38

Total

797

26.06

0.17

25.73 - 26.39

357

27.77**

0.13

27.67 - 27.87

Males

412

26.04

0.20

25.64 - 26.44

132

27.86

0.19

27.71 - 28.02

Females

385

26.07

0.24

25.61 - 26.54

225

27.72

0.17

27.58 - 27.85

Total

458

25.35

0.21

24.94 - 25.76

Males

246

25.19

0.27

24.66 - 25.73

Females

212

24.43

0.28

24.88 - 25.98

Total

140

24.26

0.41

23.46 - 25.06

Males

52

23.35

0.84

21.69 - 25.00

Females

88

24.53

0.46

23.63 - 25.42
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Table 2: Mean (standard error) of MMSE scores for the DYNOPTA baseline population and NSMH (aged 65+) as a whole, by gender and by age cohort (Continued)
90+

95+

Total

182

23.48

0.39

22.71 - 24.24

Males

62

23.15

0.75

21.67 - 24.63

Females

120

23.56

0.45

22.68 - 24.43

Total

42

21.20

0.87

19.50 - 22.91

Males

10

22.03

1.84

18.36 - 25.69

Females

32

21.10

0.94

19.25 - 22.95
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* p < .05; ** p < .001 t-test analyses between gender were computed within each study for each Age Group category. t-test analyses for between DYNOPTA and both NSMH surveys were computed
for total within each Age Group category.
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Table 3: Proportion of samples with probable dementia and possible cognitive impairment in DYNOPTA and by by gender and by age cohort
DYNOPTA

Anstey et al. BMC Neurology 2010, 10:62
http://www.biomedcentral.com/1471-2377/10/62

Female

Total

Male

Female

Total

Male

Female

Total

Proportion
(95% CI)

Proportion
(95% CI)

Proportion
(95% CI)

Proportion
(95% CI)

Proportion
(95% CI)

Proportion
(95% CI)

Proportion
(95% CI)

Proportion
(95% CI)

Proportion
(95% CI)

3.02
(0 - 7.20)

4.47
(0.55 - 8.39)

3.78
(0.87 - 6.69)

6.72
(2.27 - 11.18)*

5.70
(2.58 - 8.83)

6.22
(3.13 - 9.32)***

04.63
(0.67 - 8.59)

3.43
(0.02 - 6.83)

4.00
(1.51 - 6. 50)*

Possible cognitive impairment

5.92
(1.33 - 10.51)

3.74
(0 - 7.92)

4.78
(1.63 - 7.93)

18.65
(13.53 - 23.78)

11.07
(7.32 - 14.82)

14.91
(11.69 - 18.13)

5.72
(2.85 - 8.59)

6.35
(3.43 - 9.28)

6.05
(4.00 - 8.11)

Not Impaired

91.06
(85.77 - 96.35)

91.79
(86.37 - 97.21)

91.44
(87.60 - 95.28)

74.62
(68.15 - 81.08)

83.23
(78.50 - 87.95)

78.86
(74.56 - 83.17)

89.65
(84.71 - 94.59)

90.22
(86.36 - 94.08)

89.95
(87.03 - 92.86)

6.22
(3.14 - 9.30)

4.30
(0.75 - 7.84)

5.16
(2.57 - 7.74)

11.16
(5.55 - 16.77) *

7.66
(3.66 - 11.66)

9.09
(5.42 - 12.77)*

4.34
(1.39 - 7.29)

5.70
(2.05 - 9.36)

5.02
(2.47 - 7.58)***

Possible cognitive impairment

18.95
(15.16 - 22.75)

16.22
(11.16 - 21.28)

17.44
(14.29 - 20.59)

21.13
(14.39 - 27.87)

13.53
(9.45 - 17.61)

16.64
(12.94 - 20.35)

11.66
(6.42 - 16.90)

7.07
(3.20 - 10.95)

9.35
(6.38 - 12.32)

Not Impaired

74.83
(70.57 - 79.09)

79.49
(74.77 - 84.20)

77.40
(74.23 - 80.57)

67.71
(59.72 - 75.69)

78.82
(73.37 - 84.26)

74.26
(69.34 - 79.18)

84.00
(78.77 - 89.23)

87.23
(82.32 - 92.13)

85.63
(82.16 - 89.14)

Probable dementia

15.33
(12.90 - 17.76)

16.15
(13.70 - 18.59)

15.84
(14.03 - 17.65)

8.70
(0.99 - 16.41) *

14.69
(8.54 - 20.83)

12.63
(6.41 - 18.85)

8.51
(4.61 - 12.42)

4.91
(2.91 - 6.92)

6.55
(4.50 - 8.59)**

Possible cognitive impairment

24.75
(21.01 - 28.49)

23.25
(20.04 - 26.46)

23.81
(21.42 - 26.20)

29.01
(22.49 - 35.53)

22.11
(17.75 - 26.48)

24.48
(20.83 - 28.13)

11.14
(7.63 - 14.64)

14.29
(9.63 - 18.95)

12.86
(9.96 - 15.75)

Not Impaired

59.92
(56.24 - 63.59)

60.60
(56.95 - 64.25)

60.35
(57.63 - 63.06)

62.29
(52.94 - 71.64)

63.20
(56.14 - 70.26)

62.89
(56.08 - 69.69)

80.35
(75.02 - 85.68)

80.80
(76.08 - 85.52)

80.59
(77.10 - 84.09)

Probable dementia

10.74
(7.61 - 13.87)

10.55
(7.17 - 13.93)

10.63
(8.27 - 12.99)

-

-

-

11.26
(4.97 - 17.56)*

4.20
(1.39 - 7.01)

7.53
(4.07 - 10.99)***

Possible cognitive impairment

21.04
(16.44 - 25.64)

19.00
(14.75 - 23.26)

19.85
(16.75 - 22.94)

-

-

-

9.12
(4.52 - 13.72)

11.37
(5.53 - 17.20)

10.31
(6.24 - 14.38)

Not Impaired

68.22
(63.33 - 73.11)

70.45
(65.47 - 75.42)

69.52
(65.92 - 73.13)

-

-

-

79.61
(4.52 - 13.72)

84.43
(78.41 - 90.46)

82.16
(77.20 - 87.13)

Probable dementia

16.92
(12.40 - 21.44)

15.97
(11.44 - 20.49)

16.32
(12.99 - 19.64)

-

-

-

4.55
(0.86 - 8.24)

5.79
(2.79 - 8.79)

5.26
(3.06 - 7.45)***

Dementia Category

65-69

Probable dementia

75+

75-79

80-84

07NSMH

Male
Age

70-74

97NSMH

Probable dementia
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Table 3: Proportion of samples with probable dementia and possible cognitive impairment in DYNOPTA and by by gender and by age cohort (Continued)

85-89

90-94
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90+

95+

Possible cognitive impairment

28.47
(20.15 - 36.78)

24.23
(18.96 - 29.51)

25.79
(21.33 - 30.25)

-

-

-

14.04
(6.97 - 21.11)

17.87
(10.87 - 24.87)

16.22
(11.61 - 20.83)

Not Impaired

54.61
(47.14 - 62.09)

59.80
(53.83 - 65.78)

57.90
(53.22 - 62.58)

-

-

-

81.41
(74.37 - 88.45)

76.34
(69.48 - 83.20)

78.53
(73.75 - 83.30)

Probable dementia

25.13
(17.82 - 32.44)

21.02
(14.37 - 27.67)

22.36
(17.49- 27.24)

-

-

-

Possible cognitive impairment

31.71
(21.56 - 41.86)

31.27
(22.14 - 40.39)

31.41
(24.34 - 38.49)

-

-

-

Not Impaired

43.16
(34.59 - 51.73)

47.71
(38.71 - 56.71)

46.23
(39.00 - 53.45)

-

-

-

Probable dementia

41.27
(23.71 - 58.83)

29.89
(19.25 - 40.52)

32.43
(23.40 - 41.46)

Possible cognitive impairment

26.95
(13.61 - 40.29)

35.30
(23.74 - 46.87)

33.43
(23.91 - 42.96)

Not Impaired

31.78
(17.42 - 46.14)

34.81
(23.60 - 46.01)

34.13
(24.83 - 43.43)

Probable dementia

42.96
(26.88 - 59.05)

41.03
(31.27 - 50.80)

41.41
(33.08 - 49.74)

-

-

-

Possible cognitive impairment

28.20
(16.37 - 40.03)

29.48
(19.92 - 39.04)

29.23
(21.19 - 37.27)

-

-

-

Not Impaired

28.84
(15.97 - 41.70)

29.48
(20.22 - 38.75)

29.36
(21.52 - 37.20)

-

-

-

Probable dementia

52.75
(10.75 - 94.75)

69.39
(52.56 - 86.23)

67.52
(51.69 - 83.36)

Possible cognitive impairment

35.46
(0 - 75.17)

14.67
(0.93 - 28.41)

17.01
(4.59 - 29.43)

Not Impaired

11.79
(0 - 33.86)

15.94
(1.23 - 30.65)

15.47
(2.55 - 28.40)

* p < .05; ** p < .01; *** p < .001 Chi-Square analyses between gender and MMSE category reported in Male column. Chi-Square analyses between Study and MMSE category reported in Total column
under the NMHS surveys (ref is DYNOPTA). Yates' correction used where appropriate
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were not available to evaluate the validity of the MMSE
cut-off in the 97 NSMH or 07 NSMH.
Comparison of mean MMSE scores by age and sex

Table 2 shows the mean MMSE scores by age groups and
sex for all studies. As the breakdown of ages over 75 was
not available for the 97 NSMH, and cognitive impairment
increases with age, it was not possible to determine
whether differences in mean MMSE scores above 75 were
due to different age distributions between studies. Similarly the 07 NSMH only included data up to age 84 so that
beyond this age, there are no available survey data within
Australia for comparison with DYNOPTA.
With few exceptions, results across datasets were
highly similar. Comparison of the 97 NSMH survey with
DYNOPTA showed that the mean total MMSE was lower
in the 97 NSMH than in DYNOPTA for males aged 65 to
69, and 70 to 74. However, comparison of the 07 NSMH
survey and DYNOPTA showed that the total score was
lower in DYNOPTA for ages 70-74, 75+ and 75-79, and
80-84.
The 07 NSMH had higher mean MMSE scores than the
97 NSMH in the 65-69 (t(1338) = 6.73, p < .001) 70-74 (t
(1.58) = 6.59, p < .001) and 75+ age-groups (t (1672) =
8.71, p < .001).
Comparison of probable dementia and possible cognitive
impairment by age and sex

Table 3 shows the proportion of the DYNOPTA and
NSMH samples with probable dementia and possible
cognitive impairment according to the MMSE, split by
sex and age-group. There were no significant sex differences in rates of probable dementia or impairment in the
DYNOPTA sample. Probable dementia was more prevalent in males than females in the 65-69 age-group and 7074 age-group of the 97 NSMH. The finding that probable
dementia was less prevalent in males than females in the

Prevalence of probable or actual dementia

45

lower rates in the 75+ age-group is difficult to interpret
because information was unavailable on the distribution
of males and females in this age-group.
When males and females were combined to give a total
prevalence rate, the 97 NSMH sample for 65-69 and the
70-74 year age groups had higher rates of probable
dementia than DYNOPTA. When males and females
were combined to give a total prevalence rate for the 07
NSMH sample, there was a higher rate of probable
dementia in the 65-69 age-group, but lower rates in the
70-74 and 75+ age-groups in comparison with
DYNOPTA. There were no significant differences
between the 97 NSMH and 07 NSMH in rates of probable
dementia.
Comparison of MMSE derived cut-offs with prevalence of
dementia from meta-analyses

Table 4 shows the rates of probable dementia from
DYNOPTA and the NSMH surveys compared with the
prevalence of dementia from four meta-analyses included
in the article by Jorm et al. [2]. For those aged 65-69, and
70-74 the rates of probable dementia from MMSE estimates are clearly higher than the estimates of dementia
prevalence from clinical diagnoses, and the 97 NSMH
stands out far above all other data sources. For the 75-79
and 80-84 age-groups DYNOPTA estimates are higher
than the clinical estimates. For the 85-89 age-group and
90-94, the estimates from DYNOPTA are very similar to
estimates from studies of clinical dementia. Estimates
above the age of 95 are difficult to evaluate due to small
numbers. The estimate from 07 NSMH for the 80-84 agegroup appears to be far lower than any other published
estimate. Figure 1 shows similar trajectories with age, for
the prevalence of probable dementia derived from
DYNOPTA and the meta-analyses. If the DYNOPTA
estimates were projected onto the Australian population
in 2008, the prevalence of dementia in the 65-69, 70-74,
75-79, 80-84 and 85+ age-groups would be 31450, 34232,
58479, 69173 and 148344 respectively [32].
Education and MMSE score

40
35

DYNOPTA

30

NSMH97
NSMH07

25

Jorm

20

Lobo Female
Lobo Male

15

Ritchie
Hofman female

10

Hofman male

5
0
65-69

70-74

75-79

80-84

85-89

90-94

Figure 1 Comparisons of age trajectories of probable dementia
from Australian Surveys and meta-analyses of European Studies.

In DYNOPTA, MMSE scores differed according to level
of educational attainment. Pair-wise contrasts revealed
that individuals with tertiary qualifications (mean =
28.86, SEM = 0.99, n = 321) scored higher than those with
post-secondary qualifications (mean = 27.93, SEM = 0.83,
n = 1137, p < 0.001), secondary schooling only (mean =
27.02, SEM = 0.86, n = 2172, p < 0.001) or no formal education (mean = 23.66, SEM = 1.19, n = 14, p < 0.001). In
both the 97 NSMH and the 07 NSMH, those reporting
finishing secondary school had higher MMSE scores than
those reporting not finishing secondary school (i.e. 27.48
vs 26.83 (t ( 1786 ) = 3.212, p = .001 and 28.79 vs 28.10
(t(1903 ) = 6.770, p = .000), respectively).

Anstey et al. BMC Neurology 2010, 10:62
http://www.biomedcentral.com/1471-2377/10/62

Page 10 of 12

Table 4: Prevalence rates of probable dementia from Australian Surveys and prevalence rates of dementia from metaanalyses of European Studies
MMSE
Age Groups

60-64

DYNOPTA
[1]

NSMH97
[21]

Clinical Diagnoses
NSMH07
[22]

-

Jorm [2]

Lobo
[7]Female

Lobo
[7]Male

Ritchie [5]

Hofman
[6]Female

Hofman
[6]Male

0.7

-

-

-

-

-

65-69

3.78

6.22

4

1.4

1

1.6

1.5

-

-

70-74

5.16

9.09

5.02

2.8

3.1

2.9

3.5

3.9

4.6

75-79

10.63

-

7.53

5.6

6

5.6

6.8

6.7

5

80-84

16.32

-

5.26

10.5

12.6

11

13.6

13.5

12.1

85-89

22.36

-

-

20.8

20.2

12.8

22.3

22.8

18.5

90-94

32.43

-

-

38.6

30.8

22.1

31.5

32.2

32.1

90+

41.41

-

-

-

-

-

-

-

-

95+

67.42

-

-

-

-

-

44.5

36

31.6

Discussion
The present study reports prevalence rates of probable
dementia and possible cognitive impairment from the
two largest sources of population-based data available in
Australia, and compares these with published estimates
of dementia prevalence based on meta-analyses of
dementia prevalence from European studies. Overall the
prevalence of probable dementia derived from the
DYNOPTA dataset were comparable to estimates derived
from meta-analyses. The NSMH surveys showed less
consistency with the meta-analyses. The differing pattern
of results from these surveys and the limited availability
of age data in them suggest that these are not suitable
sources of information for making projections about
dementia or cognitive impairment in Australia. A possible explanation for the greater congruence of DYNOPTA
with the meta-analyses is that DYNOPTA MMSE data
were obtained from investigator-led epidemiological
studies where dementia and cognitive decline were a key
focus. This may have led to higher quality training of
assessors, and hence more reliable data collection and
coding.
The sensitivity and specificity of the MMSE cutoff used
in the DYNOPTA data was highly acceptable. Evaluation
of our data showed that the MMSE has a high false positive rate, suggesting that the figures for DYNOPTA may
overestimate the true level of probable dementia. A high
false positive rate is a characteristic of all screening
instruments used to detect low prevalence disorders, and
is not a limitation of the MMSE per se [33]. It therefore
appears that the DYNOPTA estimates are a reasonable
guide to the levels of cognitive impairment in Australia
but may slightly overestimate rates of actual dementia.
The prevalence of dementia in Australia based on the

2008 population statistics [32] are likely to represent the
upper end of probable dementia prevalence.
In the 97 NSMH men had higher rates of probable
dementia than women in the 65-69 and 70-74 agegroups. In the DYNOPTA sample, there were no significant differences in rates of probable dementia between
men and women. It is possible that this difference
between the survey data and some of the meta-analyses
that found higher rates of dementia in women is due to
sampling biases in the studies that contributed to the
meta-analyses. Population weights were applied to all the
survey datasets to account for sampling bias, whereas this
was not done for the studies contributing to meta-analyses, or in the meta-analyses themselves. Alternatively, the
higher life expectancy of Australian men compared to
that of males in a number of European countries [34] may
influence the population level of cognitive impairment
among men. Other possible explanations for the difference in prevalence patterns by gender include differences
in sampling frames between studies, different risk factor
profiles between countries, and possibly the higher of
education among women in Australia due to the more
recent data collection. Given the importance of establishing gender differences in prevalence for developing projections of need for dementia care, there is a need to
further investigate gender differences in studies with clinical diagnoses.
All data sources have limitations. Prevalence studies
used in meta-analyses may have sample bias, with participants who complete clinical assessments having higher
socio-economic status and education than the general
population. They often under-represent minority groups,
individuals with low literacy, and those living in rural or
remote locations. Similarly, DYNOPTA and NSMH sur-
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veys under-represented minority groups including indigenous Australians, those from culturally and linguistically
diverse groups and rural and remote locations. None of
the data reports on dementia prevalence have systematically evaluated possible cohort effects. With the increase
in IQ scores observed over the past several decades
(known as the Flynn Effect) [35] and the general increase
in health amongst cohorts moving into old age, it is possible that a reduction in dementia prevalence at older ages
will be observed due to greater cognitive reserve [36].
The MMSE has several limitations as a means of categorizing individuals with dementia and these are well
described in the literature [24,37,38]. Scores on the
MMSE are related to level of education, although education only accounts for a small proportion of variance in
scores [39]. The MMSE appears to have unacceptably
high misclassification rates among adults who are illiterate [40] but has been shown to be reliable for use in the
oldest old [41]. A strength of our study is the reporting of
standard errors and the use of population weights,
whereas confidence intervals of estimates from metaanalyses were not reported. Hence, the degree of error
associated with the estimates from meta-analyses is
unknown.

Conclusions
The data reported here confirm recent projections of the
numbers of persons with dementia in Australia [1] and
indeed suggest they may even be conservative. An overview of all the results from available sources suggests that
the rate of dementia roughly doubles every 5 years
between the ages of 70 and 84, but that the rate of
increase slows thereafter. We conclude that MMSE data
from population-based studies for which dementia or
cognitive decline is a focus, provide a valuable adjunct to
information on dementia prevalence derived from metaanalyses.
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